Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=9916725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP034885(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of ECSP034885ApublicationCriticalpatent/ECSP034885A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
El uso de un copueto de la fórmula I: y en donde los símbolos son como se definen, o un éster farmacéuticamente aceptable y disociable, o sal de adición de ácido del mismo, para la preparación de un medicamento para promover la liberación de la hormona paratiroides, por ejemplo para prevenir o tratar condiciones óseas que estén asociadas con un mayor agotamiento o resorción de calcio, o en donde sea deseable el estímulo de la formación ósea y de la fijación de calcio.The use of a co-formula of the formula I: and wherein the symbols are as defined, or a pharmaceutically acceptable and dissociable ester, or acid addition salt thereof, for the preparation of a medicament to promote the release of the hormone parathyroid, for example to prevent or treat bone conditions that are associated with increased depletion or resorption of calcium, or where stimulation of bone formation and calcium fixation is desirable.
ECSP0348852001-06-152003-12-08
QUINAZOLINE DERIVATIVES THAT PROMOTE THE RELEASE OF HORMONE PARTIROIDES
ECSP034885A
(en)